Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MGTX |
---|---|---|
09:32 ET | 637 | 4.26 |
09:36 ET | 806 | 4.24 |
09:38 ET | 100 | 4.24 |
09:39 ET | 4179 | 4.26 |
09:41 ET | 573 | 4.255 |
09:43 ET | 426 | 4.29 |
09:45 ET | 100 | 4.27 |
09:48 ET | 100 | 4.28 |
09:50 ET | 100 | 4.26 |
09:52 ET | 100 | 4.26 |
09:54 ET | 426 | 4.24 |
09:56 ET | 100 | 4.235 |
09:59 ET | 100 | 4.26 |
10:01 ET | 1300 | 4.25 |
10:06 ET | 100 | 4.27 |
10:10 ET | 100 | 4.27 |
10:12 ET | 100 | 4.255 |
10:14 ET | 100 | 4.26 |
10:15 ET | 1000 | 4.25 |
10:17 ET | 484 | 4.26 |
10:19 ET | 1626 | 4.25 |
10:21 ET | 1300 | 4.25 |
10:24 ET | 559 | 4.26 |
10:26 ET | 100 | 4.25 |
10:28 ET | 100 | 4.25 |
10:30 ET | 300 | 4.26 |
10:32 ET | 100 | 4.28 |
10:33 ET | 500 | 4.265 |
10:35 ET | 100 | 4.28 |
10:37 ET | 100 | 4.27 |
10:39 ET | 200 | 4.27 |
10:42 ET | 100 | 4.27 |
10:44 ET | 343 | 4.28 |
10:46 ET | 3528 | 4.31 |
10:48 ET | 6006 | 4.37 |
10:50 ET | 2600 | 4.34 |
10:51 ET | 100 | 4.36 |
10:55 ET | 200 | 4.3203 |
10:57 ET | 300 | 4.32 |
11:02 ET | 1652 | 4.34 |
11:04 ET | 100 | 4.33 |
11:06 ET | 317 | 4.34 |
11:08 ET | 3922 | 4.32 |
11:09 ET | 100 | 4.32 |
11:11 ET | 1178 | 4.33 |
11:13 ET | 142 | 4.3499 |
11:18 ET | 100 | 4.36 |
11:20 ET | 400 | 4.3493 |
11:22 ET | 526 | 4.34 |
11:24 ET | 400 | 4.35 |
11:26 ET | 200 | 4.33 |
11:36 ET | 2286 | 4.35 |
11:44 ET | 100 | 4.36 |
11:51 ET | 100 | 4.36 |
11:54 ET | 400 | 4.3685 |
11:58 ET | 100 | 4.37 |
12:02 ET | 4200 | 4.36 |
12:05 ET | 1400 | 4.36 |
12:07 ET | 100 | 4.34 |
12:09 ET | 100 | 4.34 |
12:16 ET | 126 | 4.33 |
12:23 ET | 200 | 4.33 |
12:30 ET | 100 | 4.325 |
12:36 ET | 100 | 4.325 |
12:39 ET | 100 | 4.325 |
12:41 ET | 100 | 4.325 |
12:50 ET | 200 | 4.325 |
12:54 ET | 2203 | 4.31 |
01:08 ET | 500 | 4.315 |
01:10 ET | 400 | 4.31 |
01:15 ET | 2400 | 4.3 |
01:26 ET | 400 | 4.3 |
01:30 ET | 791 | 4.3089 |
01:32 ET | 100 | 4.3 |
01:37 ET | 213 | 4.3 |
01:39 ET | 4100 | 4.291 |
01:42 ET | 447 | 4.2813 |
01:50 ET | 300 | 4.29 |
01:55 ET | 600 | 4.29 |
01:57 ET | 100 | 4.3 |
02:22 ET | 400 | 4.28 |
02:24 ET | 100 | 4.29 |
02:26 ET | 247 | 4.3 |
02:27 ET | 500 | 4.27 |
02:29 ET | 200 | 4.27 |
02:45 ET | 300 | 4.28 |
02:49 ET | 100 | 4.28 |
02:56 ET | 100 | 4.28 |
03:00 ET | 100 | 4.28 |
03:05 ET | 100 | 4.29 |
03:09 ET | 300 | 4.28 |
03:12 ET | 134 | 4.2737 |
03:14 ET | 200 | 4.265 |
03:25 ET | 100 | 4.27 |
03:32 ET | 100 | 4.27 |
03:34 ET | 500 | 4.27 |
03:36 ET | 200 | 4.26 |
03:41 ET | 403 | 4.26 |
03:43 ET | 4088 | 4.26 |
03:48 ET | 117 | 4.25 |
03:54 ET | 800 | 4.255 |
03:56 ET | 925 | 4.26 |
03:57 ET | 500 | 4.265 |
03:59 ET | 14679 | 4.26 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
MeiraGTx Holdings PLC | 328.0M | -2.9x | --- |
Uniqure NV | 275.6M | -0.9x | --- |
TScan Therapeutics Inc | 304.1M | -4.8x | --- |
XOMA Royalty Corp | 339.2M | -11.7x | --- |
Ocugen Inc | 348.3M | -5.7x | --- |
AC Immune SA | 314.6M | -4.9x | --- |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $328.0M |
---|---|
Revenue (TTM) | $8.1M |
Shares Outstanding | 77.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.29 |
EPS | $-1.49 |
Book Value | $2.17 |
P/E Ratio | -2.9x |
Price/Sales (TTM) | 40.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,083.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.